NEWS & EVENTS
Mologic gains ISO 13485:2003 accreditation for the provision of design and development of in vitro diagnostic medical devices for measuring proteolytic activity.
The certificate is available for viewing online at the UL ONLINE CERTIFICATIONS DIRECTORY.
Mologic continues to make excellent progress in its wound diagnostic program as it gears up for production and heads for the market.
Do you suffer from the "Not Invented Here" syndrome?
Just because something hasn't been invented yet, doesn't mean it won't or cannot exist in the future.
Difficult, Yes. Impossible, No!
AUDIO, COGNOSCO, AUDEO
I listen, I understand, and I dare.
"Mologic is an ideas rich organisation offering real diagnostics for the real world."
Mark Davis, CEO, Mologic Ltd
Mologic is proud of its collaborative network, providing first class scientific and development resources.+ learn more
Mologic has a track record of generating market ready products working both alone or in collaboration with others.+ learn more
INTRODUCTION TO MOLOGIC
WHERE WE CAME FROM
Mologic was founded in 2003 by Mark Davis and Prof Paul Davis. Their shared vision was to develop innovative, effective new concepts in diagnostic healthcare technology. A small, hand picked, dedicated team of specialists was assembled and they started to deliver. They maintained their independence through contract research with large healthcare companies. Mologic’s reputation grew and the team was expanded, acquiring new and complementary skills.
The result - a first class team of scientists who can think differently and work quickly and effectively. Mologic became part of the Alere inc. Group in October 2009.
WHERE WE ARE
Mologic now employs over 30 scientists conducting innovative biotechnology research. Our team has extensive experience in applied immunoassay technology as well as a broad understanding of medical diagnostic devices, antibody development and protein/peptide chemistry. We develop and refine new immunodiagnostic concepts and generate advanced immunoassay reagents (e.g. peptides and antibodies). We are well connected with other immunodiagnostic technology companies and with academic centres of excellence, both nationally and internationally. We have many collaborative projects with these groups. It has accepted the challenge of delivering a range of stretching goals and objectives over the next few years. We have the support and backing of Alere and are confident we can meet and even exceed these targets.
WHERE WE ARE GOING
Through our vision and creativity we find ourselves at the forefront of Alere’s scientific endeavours. We play a key role in many of the research activities central to its futureand share their vision, and believe that, despite being a small outpost of this billion dollar company, Mologic is completely aligned to assist in delivering disruptive technology for the advancing world.
Our team is our strength. Every one of us is important to our future. Working together we can meet our challenges. We must work effectively together, embrace change, whilst holding on to our basic elements of innovation, creativity and vision.